![]() |
Jerry McLarty, PhDProfessor of Medicine
LSU Health Sciences Center |
ContactPhone: (318) 813-1446 Team MembershipCancer Prevention and Control Director |
Professional Services / Education / Research / Publications
Director of a community-based cancer screening program, Partners in Wellness; Local P.I. for the nation-wide CDC Breast and Cervical Cancer Early Detection Program; Co-chair, Early Detection and Prevention Task Force for the Louisiana Cancer Control Partnership; Coordinator for the Northwest Louisiana portion of the Tobacco Control Initiative; Steering committee member, Louisiana Coalition for Tobacco Free Living; member of the Louisiana Colorectal Cancer Commission.
B.S., M.S. University of Houston, Mathematics and Computer Science
Ph.D. University of Texas Graduate School of Biomedical Sciences, Biomathematics
Cancer prevention and control. Major research interests have been in lung cancer early detection and cancer chemoprevention clinical trials. Current activities include screening and early detection, prevention clinical trials with Polyphenon E and other botanicals, and research into the effect of statins on prostate cancer risk.
Ali IU, Xiao Z, Malone W, Smith M, Conrads TP, Veenstra TD, Greenwald P, Luke BT, McLarty JW. Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers.Oncol Rep. 2006 May;15(5):1367-72.
C. Wu and J. McLarty. Neural Networks and Genome Informatics. Computational Molecular Biology Book Series, Series Editor A. Konopka. Elsevier Science, Ltd. July 2000.
McLarty, J., Antioxidants and cancer: the epidemiologic evidence. Antioxidants and Cancer, Harinder Garewal, Editor, CRC Press, New York, pp. 45-65, 1997
McLarty J., Shepherd R. Sputum cytopathology and other clinical findings as early risk factors for lung cancer in amosite asbestos workers. Lung Cancer, Vol. 29, Supplement 1, September 2000, p.226.
McLarty J.W., Holiday D.B., Girard W., Yanagihara R., and Greenberg S.D. Beta-carotene, vitamin A and lung cancer chemoprevention: results of an intermediate endpoint study. Am. J. Clin. Nutr. (Suppl) 62: 1431S-1438S, 1995
McLarty, J.W. An intervention trial in high risk asbestos-exposed persons. Ad. Exp. Med. Biol., Vol. 320: 141-149, 1992.
McLarty, J.W. Smoking, statistics and epidemiology. Seminars in Respiratory Medicine, Volume #10, Number 4: 333-344 (Invited Manuscript), October, 1989.
McLarty, J.W., How many subjects are required for a study: an important ethical question. IRB Journal, September-October, Vol. 9, No. 5, p. 1-3, 1987.
McLarty, J., Wu, C.H. Neural networks. Nature's Encyclopedia of the Human Genome. June 2003 (Invited chapter). Also in Wiley Interscience Encyclopedia of Life Sciences, July 2006.
Wu, C., H. Huang and J. McLarty. (1999). Gene family identification network design for protein sequence analysis. International Journal of Artificial Intelligence Tools, Special Issue on Biocomputing, 8 (4), 419-432.
McLarty, J.W., Risk assessment using regression models for ordered categorical data, Biometrics, Volume 40, No. 4, pp. 1194, December, 1984
Whittemore, A.S., McLarty, J.W., Fortson, N.G. and Anderson, K., Regression analysis of cytopathological data, Biometrics, Vol. 38, pp. 899-905, December, 1982